• SENSEX
    NIFTY 50
Market

Biocon shares hit 52-week high after DCGI's nod for use of Itolizumab in moderate to severe COVID patients

Updated : July 13, 2020 11:10 AM IST

The stock has gained more than 50 percent in last 6 months and over 24 percent in three months.
Biocon shares hit 52-week high after DCGI's nod for use of Itolizumab in moderate to severe COVID patients

You May Also Like

Live TV
Advertisement